These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31941862)

  • 21. Cellular and molecular mechanisms underlying bone marrow and liver fibrosis: a review.
    Le Bousse-Kerdilès MC; Martyré MC; Samson M
    Eur Cytokine Netw; 2008 Jun; 19(2):69-80. PubMed ID: 18632420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholangiographic features in fibrosis and cirrhosis of the liver. Radiological-pathological correlation.
    Altman C; Fabre M; Adrien C; Frouge C; Fritsch J; Martin E; Bléry M; Etienne JP
    Dig Dis Sci; 1995 Oct; 40(10):2128-33. PubMed ID: 7587779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.
    Yao M; Wang L; Leung PSC; Li Y; Liu S; Wang L; Guo X; Zhou G; Yan Y; Guan G; Chen X; Bowlus CL; Liu T; Jia J; Gershwin ME; Ma X; Zhao J; Lu F
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):282-294. PubMed ID: 29256057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver fibrosis.
    Aydın MM; Akçalı KC
    Turk J Gastroenterol; 2018 Jan; 29(1):14-21. PubMed ID: 29391303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
    Schuppan D; Ashfaq-Khan M; Yang AT; Kim YO
    Matrix Biol; 2018 Aug; 68-69():435-451. PubMed ID: 29656147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary liver cirrhosis and pericholangiolytic cirrhosis].
    JICHLINSKI D
    Rev Med Suisse Romande; 1961 Feb; 81():102-22. PubMed ID: 13790065
    [No Abstract]   [Full Text] [Related]  

  • 27. Relation of fibrosis of the pancreas to fatty liver and/or cirrhosis; an analysis of one thousand consecutive autopsies.
    WOLDMAN EE; FISHMAN D; SEGAL AJ
    J Am Med Assoc; 1959 Mar; 169(12):1281-3. PubMed ID: 13630751
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary biliary cirrhosis degree assessment by acoustic radiation force impulse imaging and hepatic fibrosis indicators.
    Zhang HC; Hu RF; Zhu T; Tong L; Zhang QQ
    World J Gastroenterol; 2016 Jun; 22(22):5276-84. PubMed ID: 27298571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human epididymis protein 4 concentration is not associated with liver fibrosis and cirrhosis in a case control study.
    Zhang M; Yuan L; Yao F; Cao P; Rong J; Zhang B; Su J
    Clin Chim Acta; 2018 Sep; 484():213-217. PubMed ID: 29864404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research advances in the treatment of hepatic fibrosis].
    Xia L; Yang CQ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):566-570. PubMed ID: 29056004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
    Pinzani M; Gentilini P
    Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Potential targets for anti-liver fibrosis].
    Zhao SS; Shao RG; He HW
    Yao Xue Xue Bao; 2014 Oct; 49(10):1365-71. PubMed ID: 25577864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
    Harrison SA; Abdelmalek MF; Caldwell S; Shiffman ML; Diehl AM; Ghalib R; Lawitz EJ; Rockey DC; Schall RA; Jia C; McColgan BJ; McHutchison JG; Subramanian GM; Myers RP; Younossi Z; Ratziu V; Muir AJ; Afdhal NH; Goodman Z; Bosch J; Sanyal AJ;
    Gastroenterology; 2018 Oct; 155(4):1140-1153. PubMed ID: 29990488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological changes in the thyroid in cirrhosis of the liver.
    NICOL A; SCLARE G
    J Clin Pathol; 1962 Jan; 15(1):26-30. PubMed ID: 14479499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in gene therapy of liver cirrhosis].
    Yang R; Gao J
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):30-4. PubMed ID: 15127594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of degree of liver cirrhosis using a fibrosis score; a multivariate analysis of clinical parameters and resected specimens.
    Shimada M; Matsumata T; Adachi E; Itasaka H; Watiyama S; Sugimachi K
    Hepatogastroenterology; 1994 Apr; 41(2):177-80. PubMed ID: 8056410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Regression of Cirrhosis.
    Saffioti F; Pinzani M
    Dig Dis; 2016; 34(4):374-81. PubMed ID: 27170391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver cirrhosis.
    Williams EJ; Iredale JP
    Postgrad Med J; 1998 Apr; 74(870):193-202. PubMed ID: 9683971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PNPLA3 and RNF7 Gene Variants are Associated with the Risk of Developing Liver Fibrosis and Cirrhosis in an Eastern European Population.
    Kupcinskas J; Valantiene I; Varkalaitė G; Steponaitiene R; Skieceviciene J; Sumskiene J; Petrenkiene V; Kondrackiene J; Kiudelis G; Lammert F; Kupcinskas L
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):37-43. PubMed ID: 28338112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis.
    Gómez-Dominguez E; Mendoza J; García-Buey L; Trapero M; Gisbert JP; Jones EA; Moreno-Otero R
    Aliment Pharmacol Ther; 2008 Mar; 27(5):441-7. PubMed ID: 18081731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.